Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans

Analysis reveals similar changes in the brain’s functioning in both humans and mouse models

Johns Hopkins receives $1.6 million NIH grant to commercialize innovations to treat substance use disorders

Johns Hopkins Carey Business School faculty, along with School of Medicine colleagues, will create a cutting-edge pathway for substance use disorder researchers to develop new treatment options thanks to a $1.6 million grant from the National Institute on Drug Abuse, which does not typically award grants to business schools.